Related references
Note: Only part of the references are listed.Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
Teodora P. Staeva et al.
DIABETES (2013)
Correction: Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR
Agostino Bruno et al.
PLoS One (2013)
Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling
Aram Mokarizadeh et al.
IMMUNOLOGY LETTERS (2012)
Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants A Randomized Controlled Trial
Jianming Tan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?
M. Z. Ratajczak et al.
LEUKEMIA (2012)
The Antidiabetic Effect of Mesenchymal Stem Cells Is Unrelated to Their Transdifferentiation Potential But to Their Capability to Restore Th1/Th2 Balance and to Modify the Pancreatic Microenvironment
Fernando Ezquer et al.
STEM CELLS (2012)
Crosstalk between TGF-β signaling and the microRNA machinery
Henriett Butz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
The role of membrane vesicles in tumorigenesis
Erna Pap et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
Sefina Arif et al.
DIABETES (2011)
Immunological Applications of Stem Cells in Type 1 Diabetes
Paolo Fiorina et al.
ENDOCRINE REVIEWS (2011)
Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury
Stefano Gatti et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Ruenn Chai Lai et al.
REGENERATIVE MEDICINE (2011)
Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
J. B. Matthews et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
Mollie Jurewicz et al.
DIABETES (2010)
Human Mesenchymal Stem Cells Modulate Cellular Immune Response to Islet Antigen Glutamic Acid Decarboxylase in Type 1 Diabetes
Maria M. Zanone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β
Shyam A. Patel et al.
JOURNAL OF IMMUNOLOGY (2010)
Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
Soufiane Ghannam et al.
JOURNAL OF IMMUNOLOGY (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2009)
Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells
A. M. Madec et al.
DIABETOLOGIA (2009)
Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia
Imene Boumaza et al.
JOURNAL OF AUTOIMMUNITY (2009)
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
Paolo Fiorina et al.
JOURNAL OF IMMUNOLOGY (2009)
HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor
Mikael Sundin et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
Stefania Bruno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Membrane vesicles as conveyors of immune responses
Clotilde Thery et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes
Reza Abdi et al.
DIABETES (2008)
Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the notch pathway
Yin-Ping Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
Leo Timmers et al.
Stem Cell Research (2008)
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4(+)CD25(high)FOXP3(+) regulatory T cells
Zohair Selmani et al.
STEM CELLS (2008)
Natural and TGF-β-induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2008)
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L
M. Christopeit et al.
LEUKEMIA (2008)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari et al.
BLOOD (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation
Ohad Karnieli et al.
STEM CELLS (2007)
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
Ryang Hwa Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interleukin-6 and diabetes - The good, the bad, or the indifferent?
OP Kristiansen et al.
DIABETES (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice
WN Deng et al.
DNA AND CELL BIOLOGY (2005)
Systemic transforming growth factor-β I gene therapy induces Foxp3+regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice
ZR Luo et al.
TRANSPLANTATION (2005)
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
A Augello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes
YF Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
MA Atkinson et al.
LANCET (2001)
TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu
WJ Chen et al.
IMMUNITY (2001)
Share Paper
